Literature DB >> 15934958

At the peril of dialysis patients: ignoring the failed transplant.

Juan Carlos Ayus, Steven G Achinger.   

Abstract

Recently it has been shown that patients returning to hemodialysis (HD) following kidney transplant loss have poor survival, though the factors responsible for these poor outcomes remain largely unknown. In the past, we have shown that occult infection of clotted arteriovenous grafts (AVGs) leads to a chronic inflammatory state characterized by erythropoietin resistance, hypoalbuminemia, elevated C-reactive protein (CRP), and poor outcomes. It is well known that failed renal allografts induce graft intolerance syndrome, a clinical syndrome of pain, fever, and anemia, in the majority of patients. Similarly we have shown that failed renal allografts, by their nature as a nidus of chronic immunoreactivity, also induce a chronic inflammatory state. We speculate that this chronic inflammatory state, characterized by biochemical markers of poor HD outcomes, may be responsible for the excess mortality in this group. It is currently standard practice to leave failed kidney transplants in place upon return to HD and to treat symptomatic graft intolerance syndrome with immunosuppression. While this approach may reduce clinical symptoms in the short term, treatment failure and ultimately transplant nephrectomy occur in the majority of cases. There is also evidence that continued immunosuppression can even be dangerous. It should be noted that medical treatment of graft intolerance syndrome has not been shown to reduce chronic inflammation or decrease mortality. Similarly embolization of failed kidney transplants, another option for handling failed kidney transplants, has a high rate of treatment failure, has not been shown to reduce chronic inflammation, and nothing is known about the long-term safety of this approach. Therefore failed kidney transplants in patients with biochemical markers of chronic inflammation (as is the case for infected, clotted AVGs) should be removed prior to the development of clinical symptoms in order to eliminate the chronic inflammatory state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934958     DOI: 10.1111/j.1525-139X.2005.18304.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  10 in total

1.  One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients.

Authors:  Rebecca Dahlberg; Brenda Muth; Milagros Samaniego; R Michael Hofmann; John Pirsch; Arjang Djamali
Journal:  J Ren Nutr       Date:  2010-05-26       Impact factor: 3.655

2.  Residual renal function in peritoneal dialysis with failed allograft and minimum immunosuppression.

Authors:  Nadear Elmahi; Eva Csongrádi; Kenneth Kokko; Jack R Lewin; Jamie Davison; Tibor Fülöp
Journal:  World J Transplant       Date:  2013-06-24

Review 3.  Transplant nephrectomy.

Authors:  Jacob A Akoh
Journal:  World J Transplant       Date:  2011-12-24

4.  Early but not late allograft nephrectomy reduces allosensitization after transplant failure.

Authors:  Alp Sener; Anand K Khakhar; Christopher Y Nguan; Andrew A House; Anthony M Jevnikar; Patrick P Luke
Journal:  Can Urol Assoc J       Date:  2011-03-01       Impact factor: 1.862

5.  Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Authors:  Tanushree Banerjee; S Joseph Kim; Brad Astor; Tariq Shafi; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2014-09-27       Impact factor: 8.860

6.  Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.

Authors:  Jing Zhou; Lingfeng Qin; Tai Yi; Rahmat Ali; Qingle Li; Yang Jiao; Guangxin Li; Zuzana Tobiasova; Yan Huang; Jiasheng Zhang; James J Yun; Mehran M Sadeghi; Frank J Giordano; Jordan S Pober; George Tellides
Journal:  Circ Res       Date:  2015-09-23       Impact factor: 17.367

Review 7.  Management of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomy.

Authors:  Phuong-Thu Pham; Matthew Everly; Arman Faravardeh; Phuong-Chi Pham
Journal:  World J Nephrol       Date:  2015-05-06

8.  Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients.

Authors:  Haimanot Wasse; Francesca Cardarelli; Christine De Staercke; W Craig Hooper; Qi Long
Journal:  Nephrol Dial Transplant       Date:  2012-10-22       Impact factor: 5.992

9.  Transplant nephrectomy improves survival following a failed renal allograft.

Authors:  Juan Carlos Ayus; Steven G Achinger; Shuko Lee; Mohamed H Sayegh; Alan S Go
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

10.  Pathological assessment of allograft nephrectomy: An Iranian experience.

Authors:  Hamid Mazdak; Mojgan Ghavami; Shahaboddin Dolatkhah; Parnaz Daneshpajouhnejad; Mehdi Fesharakizadeh; Shahriar Fesharakizadeh; Abdolamir Atapour; Parvin Mahzouni; Mozaffar Hashemi; Roxana Salajegheh; Diana Taheri
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.